Available online on 15.03.2025 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2025 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article                   Review Article

Holistic Approaches to managing female infertility: A comprehensive review

^a Talat Nahid, ^b Khalid Eqbal, ^c* Md Najibur Rahman, ^d Md. Mahfoozur Rahman

^a Department of PSM (Tahaffuzi Wa Samaji Tib), Government Tibbi College and Hospital, Patna, Bihar.

^b Department of Medicine (Moalajat), Sufia Unani Medical College, Hospital & Research Centre, Motihari, Bihar.

^c Department of Medicine (Moalajat), Government Tibbi College and Hospital, Patna, Bihar.

^d Department of Pharmacology (Ilmul Advia), Government Tibbi College and Hospital, Patna, Bihar.

 

 

Introduction

Female infertility is a widespread reproductive health issue characterized by the inability to conceive and sustain a pregnancy after a year of regular, unprotected intercourse¹. It affects a significant number of women globally and is attributed to various factors, including ovulatory disorders, fallopian tube obstruction, uterine abnormalities, endocrine imbalances, and age-related declines in fertility². Assisted reproductive technologies (ART) and fertility treatments, such as in vitro fertilization (IVF) and ovulation induction, are fundamental in managing infertility, offering hope to couples striving to achieve a successful pregnancy³. Additionally, lifestyle modifications, dietary interventions, stress reduction techniques, and alternative therapies are gaining recognition for their potential to improve fertility outcomes and overall well-being ⁴. Addressing female infertility requires a comprehensive, multidisciplinary approach that considers medical, psychological, and societal factors to optimize reproductive health and enhance the chances of successful conception and pregnancy⁵. Ongoing research and advancements in reproductive medicine continue to pave the way for more effective interventions and increased understanding of female infertility, empowering individuals and couples on their journey towards parenthood⁶.

The role of medicinal plants in the treatment of female infertility has garnered significant attention in recent years, driven by the increasing demand for natural and complementary therapies in reproductive health⁷. Female infertility, a complex and emotionally challenging condition, is influenced by various factors, including hormonal imbalances, ovulatory disorders, uterine abnormalities, and lifestyle-related issues⁸. 

Medicinal plants, known for their diverse bioactive compounds, exhibit a wide range of pharmacological properties, including hormone regulation, antioxidant effects, anti-inflammatory actions, and uterine toning⁹. Several plant-derived compounds, such as phytoestrogens and adaptogens, have demonstrated promising effects in restoring hormonal balance and supporting reproductive function¹⁰. Additionally, herbal remedies, when combined with lifestyle modifications, stress reduction techniques, and dietary interventions, can offer a holistic approach to enhancing fertility¹¹.

This article highlights the importance of scientific validation through controlled trials and mechanistic studies to establish the safety and efficacy of medicinal plants in female infertility management¹². While herbal treatments are gaining popularity, it is crucial to integrate them into comprehensive fertility care under the guidance of qualified healthcare professionals¹³. The collaborative efforts of traditional medicine practitioners, herbalists, and reproductive specialists are essential in advancing our understanding of the therapeutic potential of medicinal plants and optimizing their role in personalized infertility management strategies¹⁴. As research in this field continues to evolve, medicinal plants hold the promise of becoming valuable adjuncts to conventional infertility treatments, offering individuals and couples affected by female infertility a broader range of options to enhance their reproductive health and achieve their dreams of parenthood¹⁵.

Materials and methods

This comprehensive review was conducted using an extensive literature search across databases such as PubMed, Scopus, and Google Scholar. Keywords included “female infertility,” “holistic management,” “diet therapy,” “exercise,” “lifestyle changes,” “medicinal plants,” and “allopathic treatment.” Relevant studies on the effects of Withania somnifera, Rubia cordifolia, Nigella sativa, Asparagus racemosus, Asarum europaeum, and Saraca asoca were analyzed. Clinical trials, observational studies, and meta-analyses on dietary interventions, exercise, and pharmaceutical approaches were included. Data synthesis focused on efficacy, safety, and integrative benefits of holistic strategies in managing female infertility.

Causes of female infertility

Female infertility is a complex and distressing reproductive health issue that affects a significant number of women worldwide¹⁶. It is defined as the inability to conceive and maintain a pregnancy despite engaging in regular, unprotected sexual intercourse for a year or longer¹⁷. Understanding the causes of female infertility is critical for accurate diagnosis, appropriate treatment, and improving reproductive outcomes¹⁸. Here, we delve into the multifaceted factors contributing to female infertility:

Ovulatory Disorders:

Polycystic Ovary Syndrome (PCOS): PCOS is a common hormonal disorder characterized by irregular menstrual cycles, high levels of androgens, and multiple cysts on the ovaries, leading to irregular or absent ovulation¹⁹.

Hypothalamic Dysfunction: The hypothalamus, a region of the brain, plays a vital role in regulating hormone production. Disruptions in this area can affect ovulation²⁰.

Premature Ovarian Insufficiency (POI): POI, also known as early menopause, occurs when the ovaries stop functioning before the age of 40, leading to irregular or absent ovulation²¹.

Tubal and Peritoneal Factors:

Blocked or Damaged Fallopian Tubes: Previous pelvic infections, endometriosis, or previous surgeries can lead to scarring or blockages in the fallopian tubes, hindering the movement of eggs and sperm²².

Pelvic Inflammatory Disease (PID): PID, usually caused by sexually transmitted infections (STIs), can result in inflammation and scarring of the reproductive organs, including the fallopian tubes, leading to fertility issues²³.

Uterine and Cervical Factors:

Uterine Abnormalities: Congenital uterine malformations or structural abnormalities can affect implantation and the ability to carry a pregnancy to term²⁴.

Cervical Issues: Conditions such as cervical stenosis (narrowing of the cervix) or the presence of cervical mucus hostile to sperm can hinder the sperm's ability to reach the egg²⁵.

Endocrine Disorders:

Hypothyroidism and Hyperthyroidism: Imbalances in thyroid hormones can disrupt menstrual cycles and ovulation, impacting fertility²⁶.

Hyperprolactinemia: Elevated levels of the hormone prolactin can interfere with ovulation and menstrual cycles²⁷.

Diabetes: Poorly managed diabetes can affect fertility by disrupting ovulation and causing irregular menstrual cycles²⁸.

Lifestyle and Environmental Factors:

Poor Nutrition and Weight-related Issues: Being underweight or overweight can disrupt hormonal balance, affecting ovulation and fertility²⁹.

Smoking and Alcohol Consumption: Both smoking and excessive alcohol intake have been linked to decreased fertility in women³⁰.

Stress: Chronic stress can disrupt hormone levels and menstrual cycles, potentially affecting fertility³¹.

Age-related Decline in Fertility:

 Fertility decreases as a woman ages, with a significant decline typically starting after the age of 35. This is primarily due to a decrease in the quantity and quality of eggs³².

Understanding these various causes of female infertility is essential for healthcare professionals to tailor appropriate diagnostic tests and treatment plans³³. Additionally, early intervention, lifestyle modifications, and advancements in assisted reproductive technologies (ART) can significantly improve the chances of successful conception and a healthy pregnancy for those affected by infertility³⁴.

Clinical features of Female infertility

Female infertility is a complex condition characterized by the inability to conceive after a year of regular, unprotected sexual intercourse³⁵. The clinical features of female infertility can vary based on the underlying causes³⁶. Here are the key clinical features associated with female infertility:

Menstrual Irregularities:

Amenorrhea: Absence of menstruation in a woman of reproductive age, which can be categorized as primary (never having had a period) or secondary (previously menstruated but stopped having periods)³⁷.

Oligomenorrhea: Infrequent menstrual periods, typically occurring at intervals longer than 35 days³⁸.

Menorrhagia: Abnormally heavy menstrual bleeding, often with prolonged duration, which may be indicative of hormonal imbalances or structural issues in the uterus³⁹.

Dysmenorrhea: Painful menstrual periods, often accompanied by cramping, which can be caused by conditions like endometriosis or uterine fibroids⁴⁰.

Ovulatory Disorders:

Anovulation: Absence of ovulation, resulting in irregular menstrual cycles or amenorrhea. Women with anovulation may not experience the usual signs of ovulation, such as mid-cycle pain or changes in cervical mucus⁴¹.

Luteal Phase Defect: Insufficient progesterone production during the luteal phase of the menstrual cycle, potentially leading to difficulties in implantation and sustaining a pregnancy⁴².

Pelvic Pain and Discomfort:

Pelvic Inflammatory Disease (PID): Chronic or recurrent pelvic pain and discomfort may result from inflammation and scarring of the reproductive organs due to PID, which can also contribute to infertility⁴³.

Endometriosis: Painful periods, pelvic pain, pain during intercourse, and in severe cases, chronic pelvic pain can be indicative of endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus⁴⁴.

Structural Abnormalities:

Uterine Anomalies: Congenital malformations of the uterus, such as a septate or bicornuate uterus, may affect fertility by hindering implantation or causing recurrent miscarriages⁴⁵.

Tubal Abnormalities: Chronic pelvic pain or a history of pelvic infections may suggest tubal issues, including blockages or damage, potentially preventing the egg and sperm from meeting⁴⁶.

Hormonal Imbalances:

Hyperandrogenism: Clinical signs of excess androgens in conditions like Polycystic Ovary Syndrome (PCOS), such as hirsutism, acne, and male-pattern hair loss⁴⁷.

Abnormal Thyroid Function: Symptoms of hyperthyroidism or hypothyroidism, such as weight changes, fatigue, irregular periods, and mood disturbances⁴⁸.

Galactorrhea:

 Spontaneous or excessive secretion of breast milk outside of breastfeeding, often due to elevated prolactin levels, which can interfere with ovulation and menstrual cycles⁴⁹.

Pain during Sexual Intercourse (Dyspareunia):

Pain or discomfort during sexual intercourse, which can be due to various factors, including endometriosis, pelvic inflammatory disease, or vaginal dryness⁵⁰. Identifying and addressing these clinical features is crucial in diagnosing the underlying causes of female infertility and formulating appropriate treatment plans⁵¹. A comprehensive evaluation by a healthcare professional, including a thorough medical history, physical examination, and targeted diagnostic tests, is essential for effective infertility management⁵².

Complications of Female infertility

Female infertility can be associated with various emotional, physical, and social complications that significantly impact a woman's life and overall well-being⁵³. Understanding these complications is crucial for addressing the comprehensive impact of infertility on individuals and providing appropriate support⁵⁴. Here are the key complications of female infertility:

Emotional and psychological impact:

Stress and Anxiety: Infertility can cause high levels of stress and anxiety due to the pressure to conceive, repeated disappointments, and the emotional toll of fertility treatments⁵⁵.

Depression: Individuals facing infertility often experience feelings of sadness, hopelessness, and depression, affecting their overall mental health and quality of life⁵⁶.

Low Self-Esteem and Self-Worth: Fertility struggles can lead to feelings of inadequacy and negatively impact self-esteem and self-worth, affecting personal relationships and daily functioning⁵⁷.

Social Isolation: The inability to conceive may lead to withdrawal from social interactions, avoiding gatherings involving children, friends, or family, which can further exacerbate emotional distress⁵⁸.

Strained relationships:

Marital Strain: Infertility can strain relationships due to the emotional toll, blame, guilt, and disagreements on treatment options, potentially leading to marital conflicts and breakdowns ⁵⁹.

Social Relationships: Friends and family members announcing pregnancies or having children may strain friendships, causing feelings of jealousy and isolation⁶⁰.

Financial Burden:

Cost of Fertility Treatments: Fertility treatments, including in vitro fertilization (IVF), intrauterine insemination (IUI), and fertility medications, can be financially draining, especially if multiple cycles are needed⁶¹.

Lack of Insurance Coverage: Inadequate or no insurance coverage for fertility treatments can result in a significant financial burden on individuals and couples pursuing infertility treatments⁶².

Physical Health Complications:

Side Effects of Fertility Treatments: Fertility drugs and treatments can have various physical side effects, including nausea, bloating, weight gain, headaches, and multiple pregnancies (e.g., twins, triplets)⁶³.

Surgical Complications: Invasive procedures to address infertility, such as laparoscopy or hysteroscopy, carry inherent risks, including infection, bleeding, or injury to organs ⁶⁴.

Delayed Childbearing and Age-related Fertility Decline:

Advanced Maternal Age: Delayed childbearing due to infertility treatments can increase the risk of age-related fertility decline, genetic abnormalities, and complications during pregnancy ⁶⁵.

Reduced Success Rates: The longer the duration of infertility and delay in seeking treatment, the lower the success rates of fertility interventions ⁶⁶.

Impact on Career and Personal Goals:

Career Disruption: Fertility treatments may require time off work for medical appointments, treatments, and recovery, potentially impacting career progression and job stability⁶⁷.

Postponed Life Goals: Infertility can lead to a delay in achieving personal life goals, such as travel, education, or pursuing hobbies, due to the focus on fertility treatments⁶⁸.

Negative Impact on Sexual Health and Intimacy:

Sexual Dysfunction: The pressure to conceive can lead to sexual dysfunction and decreased sexual satisfaction, affecting the intimate relationship between partners⁶⁹.

Understanding and addressing these complications is essential for a comprehensive approach to infertility management⁷⁰. Providing emotional support, counseling, and a multidisciplinary approach involving healthcare professionals, mental health specialists, and support groups can significantly help individuals and couples cope with the emotional and physical challenges of infertility⁷¹.

Management of Female infertility

The management of female infertility involves a comprehensive approach aimed at identifying and addressing the underlying causes, optimizing reproductive health, and increasing the chances of achieving a successful pregnancy⁷². The management plan is personalized based on the specific causes of infertility identified through a thorough evaluation⁷³. Here are the key components of managing female infertility:

Medical Evaluation and Diagnosis:

Comprehensive History and Physical Examination: Thorough assessment of medical and reproductive history, menstrual patterns, sexual history, and lifestyle factors, along with a pelvic examination, to identify potential causes of infertility ⁷⁴.

Hormonal and Ovulatory Assessment: Blood tests to evaluate hormone levels (e.g., FSH, LH, estradiol, progesterone) throughout the menstrual cycle to assess ovulation and hormonal imbalances⁷⁵.

Ovarian Reserve Testing: Assessment of ovarian reserve through tests like Anti-Müllerian Hormone (AMH) levels, antral follicle count (AFC), and follicle-stimulating hormone (FSH) levels on specific days of the menstrual cycle⁷⁶.

Hysterosalpingography (HSG): An X-ray procedure to evaluate the uterine cavity and fallopian tubes for any structural abnormalities or blockages⁷⁷.

Transvaginal Ultrasound (TVUS): Imaging to assess the ovaries, uterus, and fallopian tubes for any structural issues⁷⁸.

Lifestyle Modifications:

Healthy Diet and Weight Management: A well-balanced diet, regular exercise, and weight management to improve overall health and optimize fertility⁷⁹.

Smoking and Alcohol Cessation: Avoidance of smoking and excessive alcohol consumption to enhance fertility and overall reproductive health⁸⁰.

Stress Management and Mental Health Support: Techniques such as yoga, meditation, counseling, and support groups to manage stress and improve mental well-being⁸¹.

Fertility Treatments:

Ovulation Induction: Stimulating ovulation through medications like Clomiphene citrate or gonadotropins to increase the chances of conceiving ⁸².

Intrauterine Insemination (IUI): Placing sperm directly into the uterus during the woman's fertile window to enhance the chances of fertilization ⁸³.

In Vitro Fertilization (IVF): Fertilizing an egg with sperm outside the body and transferring the resulting embryo(s) into the uterus ⁸⁴.

Intracytoplasmic Sperm Injection (ICSI): Directly injecting a single sperm into an egg during IVF, often used in cases of male infertility⁸⁵.

Donor Eggs or Sperm: Using donated eggs or sperm when needed ⁸⁴

Surgery:

Laparoscopy or Hysteroscopy: Minimally invasive surgical procedures to diagnose and correct issues such as endometriosis, uterine abnormalities, or tubal blockages⁸⁷.

Myomectomy: Surgical removal of uterine fibroids that may be interfering with fertility⁸⁸.

Assisted Reproductive Technologies (ART):

Egg Freezing: Preserving a woman's eggs for future use, often considered for those undergoing cancer treatment or delaying childbearing⁸⁹.

Surrogacy: Involves another woman carrying and delivering a baby for a couple unable to conceive⁹⁰.

Management of female infertility should be individualized, considering the specific causes and unique circumstances of each woman or couple⁹¹. Collaboration between healthcare providers, reproductive specialists, mental health professionals, and support groups is crucial to provide holistic and effective management options for achieving a successful pregnancy⁹².

Role of Medicinal Plants in Treating Female Infertility

Infertility is a common reproductive health concern affecting many women worldwide. It can result from various factors, including hormonal imbalances, oxidative stress, lifestyle changes, and underlying medical conditions⁹³. Traditional and alternative medicine systems, particularly Ayurveda and herbal medicine, have long utilized medicinal plants to address infertility issues⁹⁴. This article explores the therapeutic roles of six key medicinal plants-Withania somnifera (Ashwagandha), Rubia cordifolia (Manjistha), Nigella sativa (Kalonji), Asparagus racemosus (Shatavari), Asarum europaeum (Asarun), and Saraca asoca (Ashoka)-in treating female infertility⁹⁵.

1. Withania somnifera (Ashwagandha)

Ashwagandha is a well-known adaptogenic herb widely used in Ayurveda to promote reproductive health. It plays a significant role in treating female infertility through the following mechanisms:

• Regulating Hormonal Imbalance: Ashwagandha helps maintain hormonal balance by influencing the hypothalamic-pituitary-ovarian (HPO) axis, which is crucial for regular ovulation and menstrual cycles.
• Reducing Stress and Anxiety: Chronic stress and anxiety are significant contributors to infertility. Ashwagandha is known to lower cortisol levels, reducing stress and its negative impact on fertility.
• Enhancing Ovarian Function: Studies suggest that Ashwagandha improves ovarian reserve by increasing follicular count and supporting ovulation.
• Boosting Libido and Sexual Health: Ashwagandha is traditionally used to enhance sexual function, which can positively affect conception rates.
• Antioxidant and Anti-inflammatory Properties: It combats oxidative stress, which can damage reproductive tissues and hinder fertility⁹⁶.

2. Rubia cordifolia (Manjistha)

Manjistha is renowned for its blood-purifying properties and plays a vital role in improving female reproductive health:

• Detoxification and Blood Purification: A healthy reproductive system requires proper blood circulation. Manjistha helps eliminate toxins and enhances blood flow to the reproductive organs.
• Regulating Menstrual Disorders: It helps manage irregular menstrual cycles, which are often a barrier to conception.
• Reducing Endometriosis and PCOS Symptoms: Its anti-inflammatory properties alleviate endometriosis and polycystic ovary syndrome (PCOS), both of which contribute to infertility.
• Supporting Uterine Health: Manjistha helps maintain the uterine lining, creating a favorable environment for implantation⁹⁷.

3. Nigella sativa (Kalonji)

Nigella sativa, commonly known as black cumin or Kalonji, is a potent medicinal herb with various reproductive health benefits:

• Hormonal Balance and Ovulation Regulation: Kalonji is known to regulate estrogen and progesterone levels, ensuring proper ovulation.
• Improving Egg Quality: The high antioxidant content of Kalonji protects ovarian follicles from oxidative damage.
• Managing PCOS: It has been shown to reduce insulin resistance and androgen levels, helping women with PCOS regain normal ovulation.
• Enhancing Fertility Through Anti-inflammatory Effects: Kalonji’s anti-inflammatory properties support reproductive tissue health and reduce uterine inflammation.
• Immune System Support: A strong immune system is essential for successful conception, and Kalonji boosts immunity to improve overall health ⁹⁸.

4. Asparagus racemosus (Shatavari)

Shatavari, known as the ‘queen of herbs’ in Ayurveda, is one of the most powerful herbal remedies for female fertility:

• Promoting Ovarian Function: Shatavari contains phytoestrogens that help regulate estrogen levels, essential for ovarian health and regular menstruation.
• Supporting Healthy Cervical Mucus Production: It enhances cervical mucus quality, which aids sperm motility and fertilization.
• Reducing Uterine Disorders: Shatavari strengthens and tones the uterus, improving implantation success rates.
• Enhancing Libido and Sexual Health: It acts as an aphrodisiac, increasing sexual desire and reproductive vitality.
• Preventing Recurrent Miscarriages: By nourishing the endometrial lining, it reduces the risk of early pregnancy loss⁹⁹.

5. Asarum europaeum (Asarun)

Asarum europaeum, commonly known as Asarun, has traditional uses in treating reproductive disorders:

• Regulating Menstrual Cycles: Asarun supports menstrual regularity, which is crucial for ovulation and conception.
• Reducing Pelvic Congestion and Inflammation: It alleviates pelvic congestion, which can interfere with conception.
• Stimulating Uterine Circulation: Proper blood flow to the uterus ensures a healthy endometrial lining, essential for implantation.
• Supporting Detoxification: It helps remove reproductive toxins, enhancing fertility.
• Reducing Painful Menstruation (Dysmenorrhea): Its analgesic properties provide relief from menstrual cramps and associated discomfort ¹⁰⁰.

6. Saraca asoca (Ashoka)

Saraca asoca, commonly known as Ashoka, is one of the most revered herbs for treating gynecological disorders:

• Managing Menstrual Irregularities: Ashoka regulates menstrual cycles, ensuring ovulation and reproductive health.
• Strengthening the Uterus: It improves uterine tone, supporting healthy implantation and pregnancy maintenance.
• Treating Endometriosis and Fibroids: Ashoka’s anti-inflammatory properties help reduce fibroids and endometrial overgrowth, which can cause infertility.
• Hormonal Regulation: It helps balance reproductive hormones, reducing issues such as estrogen dominance.
• Supporting Postpartum Recovery: Ashoka aids in post-delivery uterine recovery, enhancing overall reproductive health¹⁰¹.

Conclusion

Managing female infertility requires a multifaceted approach that integrates conventional medical treatments with holistic strategies to optimize reproductive health. A comprehensive approach includes diet therapy, regular exercise, lifestyle modifications, and the use of medicinal plants, alongside allopathic treatments. Proper nutrition plays a crucial role in hormonal balance and overall reproductive function, while exercise and lifestyle adjustments help regulate stress, maintain a healthy weight, and enhance fertility outcomes. Herbal remedies such as Withania somnifera (Ashwagandha), Rubia cordifolia (Manjistha), Nigella sativa (Kalonji), Asparagus racemosus (Shatavari), Asarum europaeum (Asarun), and Saraca asoca (Ashoka) have shown potential in improving fertility by enhancing ovarian function, reducing inflammation, and regulating hormonal imbalances. These natural remedies, when combined with allopathic treatments, can provide a synergistic effect in treating infertility. A holistic approach addresses not only the physiological aspects of infertility but also emotional and psychological well-being, which are crucial for conception. By integrating traditional and modern medical practices, women struggling with infertility can achieve better reproductive health and improved chances of conception. Future research should focus on further validating the efficacy of holistic treatments, ensuring their safety, and developing personalized fertility management plans for women worldwide.

Acknowledgements: The authors would like to thank all researchers whose work has contributed to the development of this field. We also appreciate the valuable insights from colleagues and peer reviewers who helped improve the quality of this manuscript.

Author Contributions: All authors contributed equally to the conception, design, data collection, analysis, and writing of the manuscript. All authors reviewed and approved the final version of the manuscript.

Competing interest: The authors declare that they have no competing interests.

Funding: Nil

Ethical approval: Not applicable

References:

1. Walker MH, Tobler KJ. Female Infertility. 2022 Dec 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 32310493.

2. Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. JAMA. 2021 Jul 6;326(1):65-76. https://doi.org/10.1001/jama.2021.4788 PMid:34228062 PMCid:PMC9302705

3. Jain M, Singh M. Assisted Reproductive Technology (ART) Techniques. 2023 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 35015434.

4. Emokpae MA, Brown SI. Effects of lifestyle factors on fertility: practical recommendations for modification. Reprod Fertil. 2021 Jan 8;2(1):R13-R26. https://doi.org/10.1530/RAF-20-0046 PMid:35128442 PMCid:PMC8812443

5. Skoracka K, Ratajczak AE, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Female Fertility and the Nutritional Approach: The Most Essential Aspects. Adv Nutr. 2021 Dec 1;12(6):2372-2386. https://doi.org/10.1093/advances/nmab068 PMid:34139003 PMCid:PMC8634384

6. Shandilya R, Pathak N, Lohiya NK, Sharma RS, Mishra PK. Nanotechnology in reproductive medicine: Opportunities for clinical translation. Clin Exp Reprod Med. 2020 Dec;47(4):245-262. https://doi.org/10.5653/cerm.2020.03650 PMid:33227186 PMCid:PMC7711096

7. Akbaribazm M, Goodarzi N, Rahimi M. Female infertility and herbal medicine: An overview of the new findings. Food Sci Nutr. 2021 Aug 15;9(10):5869-5882. https://doi.org/10.1002/fsn3.2523 PMid:34646552 PMCid:PMC8498057

8. Kamboj N, Saraswathy KN, Prasad S, Babu N, Puri M, Sharma A, Dhingra S, Sachdeva MP, Mahajan C. Women infertility and common mental disorders: A cross-sectional study from North India. PLoS One. 2023 Jan 5;18(1):e0280054. https://doi.org/10.1371/journal.pone.0280054 PMid:36603005 PMCid:PMC9815660

9. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis. 2017 Apr 15;7(2):19-32.

10. Canivenc-Lavier MC, Bennetau-Pelissero C. Phytoestrogens and Health Effects. Nutrients. 2023 Jan 9;15(2):317. https://doi.org/10.3390/nu15020317 PMid:36678189 PMCid:PMC9864699

11. Balkrishna A, Rana M, Mishra S, Srivastava D, Bhardwaj R, Singh S, Rajput SK, Arya V. Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management. Evid Based Complement Alternat Med. 2023 Jun 20;2023:3705508. https://doi.org/10.1155/2023/3705508 PMid:37383339 PMCid:PMC10299884

12. Hyun JY, Jung HS, Park JY. Herbal therapeutics for female infertility: A systematic review and meta-analysis. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117258. https://doi.org/10.1016/j.jep.2023.117258 PMid:37778518

13. James PB, Taidy-Leigh L, Bah AJ, Kanu JS, Kangbai JB, Sevalie S. Prevalence and Correlates of Herbal Medicine Use among Women Seeking Care for Infertility in Freetown, Sierra Leone. Evid Based Complement Alternat Med. 2018 Apr 22;2018:9493807. https://doi.org/10.1155/2018/9493807 PMid:29849738 PMCid:PMC5937420

14. Rizvi SAA, Einstein GP, Tulp OL, Sainvil F, Branly R. Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases. Biomolecules. 2022 Oct 9;12(10):1442. https://doi.org/10.3390/biom12101442 PMid:36291651 PMCid:PMC9599697

15. Smith JF, Eisenberg ML, Millstein SG, Nachtigall RD, Shindel AW, Wing H, Cedars M, Pasch L, Katz PP; Infertility Outcomes Program Project Group. The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States. Fertil Steril. 2010 May 1;93(7):2169-74. https://doi.org/10.1016/j.fertnstert.2010.02.054 PMid:20338559 PMCid:PMC2860047

16. Abrao MS, Muzii L, Marana R. Anatomical causes of female infertility and their management. Int J Gynaecol Obstet. 2013 Dec;123 Suppl 2:S18-24. https://doi.org/10.1016/j.ijgo.2013.09.008 PMid:24119894

17. Madziyire MG, Magwali TL, Chikwasha V, Mhlanga T. The causes of infertility in women presenting to gynaecology clinics in Harare, Zimbabwe; a cross sectional study. Fertil Res Pract. 2021 Jan 5;7(1):1. https://doi.org/10.1186/s40738-020-00093-0 PMid:33397485 PMCid:PMC7781825

18. Luciano AA, Lanzone A, Goverde AJ. Management of female infertility from hormonal causes. Int J Gynaecol Obstet. 2013 Dec;123 Suppl 2:S9-17. https://doi.org/10.1016/j.ijgo.2013.09.007 PMid:24139473

19. Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM; FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO ovulatory disorders classification system. Int J Gynaecol Obstet. 2022 Oct;159(1):1-20. https://doi.org/10.1002/ijgo.14331 PMid:35983674 PMCid:PMC10086853

20. Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, et al. FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO Ovulatory Disorders Classification System†. Hum Reprod. 2022 Sep 30;37(10):2446-2464. https://doi.org/10.1093/humrep/deac180 PMid:35984284 PMCid:PMC9527465

21. Balen AH, Tamblyn J, Skorupskaite K, Munro MG. A comprehensive review of the new FIGO classification of ovulatory disorders. Hum Reprod Update. 2024 May 2;30(3):355-382. https://doi.org/10.1093/humupd/dmae003 PMid:38412452

22. Ambildhuke K, Pajai S, Chimegave A, Mundhada R, Kabra P. A Review of Tubal Factors Affecting Fertility and its Management. Cureus. 2022 Nov 1;14(11):e30990. https://doi.org/10.7759/cureus.30990 PMid:36475176 PMCid:PMC9717713

23. Jennings LK, Krywko DM. Pelvic Inflammatory Disease. 2023 Mar 13. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 29763134.

24. Jayaprakasan K, Ojha K. Diagnosis of Congenital Uterine Abnormalities: Practical Considerations. J Clin Med. 2022 Feb 25;11(5):1251. https://doi.org/10.3390/jcm11051251 PMid:35268343 PMCid:PMC8911320

25. Ludmir J, Sehdev HM. Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol. 2000 Sep;43(3):433-9. https://doi.org/10.1097/00003081-200009000-00003 PMid:10949747

26. Mintziori G, Kita M, Duntas L, Goulis DG. Consequences of hyperthyroidism in male and female fertility: pathophysiology and current management. J Endocrinol Invest. 2016 Aug;39(8):849-53. https://doi.org/10.1007/s40618-016-0452-6 PMid:26956000

27. Dehghan E, Namiranian N, Ghadiri-Anari A, Kazem Razavi Ratki S, Azizi R. Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study. Int J Reprod Biomed. 2022 Jan 12;19(12):1085-1090. https://doi.org/10.18502/ijrm.v19i12.10059 PMid:35098010 PMCid:PMC8792383

28. Condorelli RA, La Vignera S, Mongioì LM, Alamo A, Calogero AE. Diabetes Mellitus and Infertility: Different Pathophysiological Effects in Type 1 and Type 2 on Sperm Function. Front Endocrinol (Lausanne). 2018 May 25;9:268. https://doi.org/10.3389/fendo.2018.00268 PMid:29887834 PMCid:PMC5980990

29. Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):111-7. https://doi.org/10.5152/jtgga.2015.15232 PMid:26097395 PMCid:PMC4456969

30. de Jong AM, Menkveld R, Lens JW, Nienhuis SE, Rhemrev JP. Effect of alcohol intake and cigarette smoking on sperm parameters and pregnancy. Andrologia. 2014 Mar;46(2):112-7. https://doi.org/10.1111/and.12054 PMid:23230969

31. Rooney KL, Domar AD. The relationship between stress and infertility. Dialogues Clin Neurosci. 2018 Mar;20(1):41-47. https://doi.org/10.31887/DCNS.2018.20.1/klrooney PMid:29946210 PMCid:PMC6016043

32. Owen A, Carlson K, Sparzak PB. Age-Related Fertility Decline. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 35015465.

33. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014 Mar;101(3):633-4. https://doi.org/10.1016/j.fertnstert.2013.12.032 PMid:24559617

34. Graham ME, Jelin A, Hoon AH Jr, Wilms Floet AM, Levey E, Graham EM. Assisted reproductive technology: Short- and long-term outcomes. Dev Med Child Neurol. 2023 Jan;65(1):38-49. https://doi.org/10.1111/dmcn.15332 PMid:35851656 PMCid:PMC9809323

35. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018 Dec;62:2-10. https://doi.org/10.1016/j.clinbiochem.2018.03.012 PMid:29555319

36. Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. JAMA. 2021 Jul 6;326(1):65-76. https://doi.org/10.1001/jama.2021.4788 PMid:34228062 PMCid:PMC9302705

37. Cao Y, Zhao X, Dou Z, Gong Z, Wang B, Xia T. The correlation between menstrual characteristics and fertility in women of reproductive age: a systematic review and meta-analysis. Fertil Steril. 2024 Nov;122(5):918-927. https://doi.org/10.1016/j.fertnstert.2024.06.016 PMid:38936536

38. Kolstad HA, Bonde JP, Hjøllund NH, Jensen TK, Henriksen TB, Ernst E, Giwercman A, Skakkebaek NE, Olsen J. Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy. Fertil Steril. 1999 Mar;71(3):490-6. https://doi.org/10.1016/S0015-0282(98)00474-9 PMid:10065787

39. Attia GM, Alharbi OA, Aljohani RM. The Impact of Irregular Menstruation on Health: A Review of the Literature. Cureus. 2023 Nov 20;15(11):e49146. https://doi.org/10.7759/cureus.49146

40. Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Res. 2017 Sep 5;6:1645. https://doi.org/10.12688/f1000research.11682.1 PMid:28944048 PMCid:PMC5585876

41. Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM; FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO ovulatory disorders classification system. Int J Gynaecol Obstet. 2022 Oct;159(1):1-20. https://doi.org/10.1002/ijgo.14331 PMid:35983674 PMCid:PMC10086853

42. Skowrońska M, Pawłowski M, Milewski R. A Literature Review and a Proposed Classification of the Relationships between Ovulatory Infertility and Lifestyle Factors Based on the Three Groups of Ovulation Disorders Classified by WHO. J Clin Med. 2023 Sep 28;12(19):6275. https://doi.org/10.3390/jcm12196275 PMid:37834919 PMCid:PMC10573907

43. Santulli P, Bourdon M, Desportes C, Maignien C, Pocate-Cheriet K, Patrat C, Marcellin L, Chapron C. Assessment of the Pelvic Pain Experienced by Infertile Women is of Prime Importance for Diagnosing Endometriosis. J Minim Invasive Gynecol. 2024 Nov;31(11):943-950.e1. https://doi.org/10.1016/j.jmig.2024.07.010 PMid:39033906

44. Filip L, Duică F, Prădatu A, Crețoiu D, Suciu N, Crețoiu SM, Predescu DV, Varlas VN, Voinea SC. Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches. Medicina (Kaunas). 2020 Sep 9;56(9):460. https://doi.org/10.3390/medicina56090460 PMid:32916976 PMCid:PMC7559069

45. Sevindik B, Unver Dogan N, Secilmis O, Uysal E, Fazliogullari Z, Karabulut AK. Differences in the anatomical structure of the uterus between fertile and infertile individuals. Clin Anat. 2023 Jul;36(5):764-769. https://doi.org/10.1002/ca.24045 PMid:37092771

46. El-Kharoubi AF. Tubal Pathologies and Fertility Outcomes: A Review. Cureus. 2023 May 11;15(5):e38881. https://doi.org/10.7759/cureus.38881

47. Abruzzese GA, Silva AF, Velazquez ME, Ferrer MJ, Motta AB. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development. WIREs Mech Dis. 2022 Sep;14(5):e1558. https://doi.org/10.1002/wsbm.1558 PMid:35475329

48. Mazzilli R, Medenica S, Di Tommaso AM, Fabozzi G, Zamponi V, Cimadomo D, Rienzi L, Ubaldi FM, Watanabe M, Faggiano A, La Vignera S, Defeudis G. The role of thyroid function in female and male infertility: a narrative review. J Endocrinol Invest. 2023 Jan;46(1):15-26. https://doi.org/10.1007/s40618-022-01883-7 PMid:35945393 PMCid:PMC9829629

49. Ugwa EA, Ashimi AO, Abubakar MY, Takai IU, Lukman OT, Lawal HA, Also MA, Gift AN, Kiri HM. An assessment of serum prolactin levels among infertile women with galactorrhea attending a gynecological clinic North-West Nigeria. Niger Med J. 2016 May-Jun;57(3):178-81. https://doi.org/10.4103/0300-1652.184068 PMid:27397959 PMCid:PMC4924401

50. Wahl KJ, Orr NL, Lisonek M, Noga H, Bedaiwy MA, Williams C, Allaire C, Albert AY, Smith KB, Cox S, Yong PJ. Deep Dyspareunia, Superficial Dyspareunia, and Infertility Concerns Among Women With Endometriosis: A Cross-Sectional Study. Sex Med. 2020 Jun;8(2):274-281. https://doi.org/10.1016/j.esxm.2020.01.002 PMid:32061579 PMCid:PMC7261667

51. Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, Field N, Nunns D, Bancroft J, Jones KG, Johnson AM, Mercer CH. Painful sex (dyspareunia) in women: prevalence and associated factors in a British population probability survey. BJOG. 2017 Oct;124(11):1689-1697. dhttps://doi.org/10.1111/1471-0528.14518 PMid:28120373 PMCid:PMC5638059

52. Privitera G, O'Brien K, Misajon R, Lin CY. Endometriosis Symptomatology, Dyspareunia, and Sexual Distress Are Related to Avoidance of Sex and Negative Impacts on the Sex Lives of Women with Endometriosis. Int J Environ Res Public Health. 2023 Feb 14;20(4):3362. https://doi.org/10.3390/ijerph20043362 PMid:36834055 PMCid:PMC9967948

53. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018 Dec;62:2-10. https://doi.org/10.1016/j.clinbiochem.2018.03.012 PMid:29555319

54. Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J. Female infertility, infertility-associated diagnoses, and comorbidities: a review. J Assist Reprod Genet. 2017 Feb;34(2):167-177. https://doi.org/10.1007/s10815-016-0836-8 PMid:27817040 PMCid:PMC5306404

55. Bindeman J, Abbasi R, Sacks PC. The Mental Health Traumas of Infertility: Impact and Consequences. Obstet Gynecol Clin North Am. 2025 Mar;52(1):133-143. https://doi.org/10.1016/j.ogc.2024.10.005 PMid:39880560

56. Sharma A, Shrivastava D. Psychological Problems Related to Infertility. Cureus. 2022 Oct 15;14(10):e30320. https://doi.org/10.7759/cureus.30320

57. Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol. 2007 Apr;21(2):293-308. dhttps://doi.org/10.1016/j.bpobgyn.2006.12.003 PMid:17241818

58. Hasanpoor-Azghdy SB, Simbar M, Vedadhir A. The emotional-psychological consequences of infertility among infertile women seeking treatment: Results of a qualitative study. Iran J Reprod Med. 2014 Feb;12(2):131-8.

59. Simionescu G, Doroftei B, Maftei R, Obreja BE, Anton E, Grab D, Ilea C, Anton C. The complex relationship between infertility and psychological distress (Review). Exp Ther Med. 2021 Apr;21(4):306. https://doi.org/10.3892/etm.2021.9737 PMid:33717249 PMCid:PMC7885086

60. Tao P, Coates R, Maycock B. Investigating marital relationship in infertility: a systematic review of quantitative studies. J Reprod Infertil. 2012 Apr;13(2):71-80.

61. Lai JD, Fantus RJ, Cohen AJ, Wan V, Hudnall MT, Pham M, Brannigan RE, Halpern JA. Unmet financial burden of infertility care and the impact of state insurance mandates in the United States: analysis from a popular crowdfunding platform. Fertil Steril. 2021 Oct;116(4):1119-1125. https://doi.org/10.1016/j.fertnstert.2021.05.111 PMid:34246467

62. Bourrion B, Panjo H, Bithorel PL, de La Rochebrochard E, François M, Pelletier-Fleury N. The economic burden of infertility treatment and distribution of expenditures overtime in France: a self-controlled pre-post study. BMC Health Serv Res. 2022 Apr 15;22(1):512. https://doi.org/10.1186/s12913-022-07725-9 PMid:35428284 PMCid:PMC9013027

63. Xie F, You Y, Guan C, Gu Y, Yao F, Xu J. Association between physical activity and infertility: a comprehensive systematic review and meta-analysis. J Transl Med. 2022 May 23;20(1):237. https://doi.org/10.1186/s12967-022-03426-3 PMid:35606876 PMCid:PMC9125843

64. Brinson AK, da Silva SG, Hesketh KR, Evenson KR. Impact of Physical Activity and Sedentary Behavior on Spontaneous Female and Male Fertility: A Systematic Review. J Phys Act Health. 2023 May 5;20(7):600-615. https://doi.org/10.1123/jpah.2022-0487 PMid:37146984 PMCid:PMC7614776

65. Balasch J, Gratacós E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012 Jun;24(3):187-93. https://doi.org/10.1097/GCO.0b013e3283517908 PMid:22450043

66. Balasch J, Gratacós E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Fetal Diagn Ther. 2011;29(4):263-73. https://doi.org/10.1159/000323142 PMid:21228557

67. Owen A, Carlson K, Sparzak PB. Age-Related Fertility Decline. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. PMID: 35015465.

68. Lawson AK, McQueen DB, Swanson AC, Confino R, Feinberg EC, Pavone ME. Psychological distress and postponed fertility care during the COVID-19 pandemic. J Assist Reprod Genet. 2021 Feb;38(2):333-341. https://doi.org/10.1007/s10815-020-02023-x PMid:33400078 PMCid:PMC7783482

69. Starc A, Trampuš M, Pavan Jukić D, Rotim C, Jukić T, Polona Mivšek A. INFERTILITY AND SEXUAL DYSFUNCTIONS: A SYSTEMATIC LITERATURE REVIEW. Acta Clin Croat. 2019 Sep;58(3):508-515. https://doi.org/10.20471/acc.2019.58.03.15

70. Leeners B, Tschudin S, Wischmann T, Kalaitzopoulos DR. Sexual dysfunction and disorders as a consequence of infertility: a systematic review and meta-analysis. Hum Reprod Update. 2023 Jan 5;29(1):95-125. https://doi.org/10.1093/humupd/dmac030 PMid:35900268

71. Lotti F, Maggi M. Sexual dysfunction and male infertility. Nat Rev Urol. 2018 May;15(5):287-307. https://doi.org/10.1038/nrurol.2018.20 PMid:29532805

72. Chambers GM, Harrison C, Raymer J, Petersen Raymer AK, Britt H, Chapman M, Ledger W, Norman RJ. Infertility management in women and men attending primary care-patient characteristics, management actions and referrals. Hum Reprod. 2019 Nov 1;34(11):2173-2183. https://doi.org/10.1093/humrep/dez172 PMid:31725877

73. Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA. 2003 Oct 1;290(13):1767-70. https://doi.org/10.1001/jama.290.13.1767 PMid:14519712

74. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015 Jun;103(6):e44-50. https://doi.org/10.1016/j.fertnstert.2015.03.019

75. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021 Nov;116(5):1255-1265. https://doi.org/10.1016/j.fertnstert.2021.08.038 PMid:34607703

76. Phillips K, Olanrewaju RA, Omole F. Infertility: Evaluation and Management. Am Fam Physician. 2023 Jun;107(6):623-630.

77. Schankath AC, Fasching N, Urech-Ruh C, Hohl MK, Kubik-Huch RA. Hysterosalpingography in the workup of female infertility: indications, technique and diagnostic findings. Insights Imaging. 2012 Oct;3(5):475-83. https://doi.org/10.1007/s13244-012-0183-y PMid:22802083 PMCid:PMC3443271

78. Thaker N, Dhande R, Parihar P. Role of Transvaginal Sonography in the Diagnosis of Female Infertility: A Comprehensive Review. Cureus. 2023 Dec 6;15(12):e50048. https://doi.org/10.7759/cureus.50048

79. Fabozzi G, Verdone G, Allori M, Cimadomo D, Tatone C, Stuppia L, Franzago M, Ubaldi N, Vaiarelli A, Ubaldi FM, Rienzi L, Gennarelli G. Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation. Nutrients. 2022 May 3;14(9):1918. https://doi.org/10.3390/nu14091918 PMid:35565885 PMCid:PMC9105997

80. de Angelis C, Nardone A, Garifalos F, Pivonello C, Sansone A, Conforti A, Di Dato C, Sirico F, Alviggi C, Isidori A, Colao A, Pivonello R. Smoke, alcohol and drug addiction and female fertility. Reprod Biol Endocrinol. 2020 Mar 12;18(1):21. https://doi.org/10.1186/s12958-020-0567-7 PMid:32164734 PMCid:PMC7069005

81. Mori A. Supporting stress management for women undergoing the early stages of fertility treatment: a cluster-randomized controlled trial. Jpn J Nurs Sci. 2009 Jun;6(1):37-49. https://doi.org/10.1111/j.1742-7924.2009.00119.x PMid:19566638

82. Huseyin K, Berk B, Tolga K, Eser O, Ali G, Murat A. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism. J Gynecol Obstet Hum Reprod. 2019 Dec;48(10):833-838. https://doi.org/10.1016/j.jogoh.2019.03.027 PMid:30930300

83. Allahbadia GN. Intrauterine Insemination: Fundamentals Revisited. J Obstet Gynaecol India. 2017 Dec;67(6):385-392. https://doi.org/10.1007/s13224-017-1060-x PMid:29162950 PMCid:PMC5676579

84. Mahabbat NA, Khan TA, Elyas MF, Mahabbat AA, Oraif AM. Role of In Vitro Fertilization (IVF) in Unexplained Infertility Management: A Systematic Review. Cureus. 2024 Oct 28;16(10):e72527. https://doi.org/10.7759/cureus.72527 PMid:39606509 PMCid:PMC11600464

85. Yang L, Liang F, Zhu R, Wang Q, Yao L, Zhang X. Efficacy of intracytoplasmic sperm injection in women with non-male factor infertility: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2024 Jan;103(1):30-41. https://doi.org/10.1111/aogs.14698 PMid:37930100 PMCid:PMC10755139

86. Nayak PK, Mahapatra PC, Mallick J, Swain S, Mitra S, Sahoo J. Role of diagnostic hystero-laparoscopy in the evaluation of infertility: A retrospective study of 300 patients. J Hum Reprod Sci. 2013 Jan;6(1):32-4. https://doi.org/10.4103/0974-1208.112378 PMid:23869148 PMCid:PMC3713574

87. Carranza-Mamane B, Havelock J, Hemmings R; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE; SPECIAL CONTRIBUTOR. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. https://doi.org/10.1016/S1701-2163(15)30318-2 PMid:26001875

88. Cobo A, García-Velasco JA. Why all women should freeze their eggs. Curr Opin Obstet Gynecol. 2016 Jun;28(3):206-10. https://doi.org/10.1097/GCO.0000000000000269 PMid:27031375

89. Musavi S, Mashhadi Abdolahi H, Ghojazadeh M, Abbasalizad Farhangi M, Nikniaz Z, Nikniaz L. Infertile Women's Opinion Concerning Gestational Surrogacy: A Systematic Review and Meta-Analysis. Iran J Public Health. 2020 Aug;49(8):1432-1438. https://doi.org/10.18502/ijph.v49i8.3866 PMid:33083319 PMCid:PMC7554397

90. Graham ME, Jelin A, Hoon AH Jr, Wilms Floet AM, Levey E, Graham EM. Assisted reproductive technology: Short- and long-term outcomes. Dev Med Child Neurol. 2023 Jan;65(1):38-49. https://doi.org/10.1111/dmcn.15332 PMid:35851656 PMCid:PMC9809323

91. Sparaco M, Carbone L, Landi D, Ingrasciotta Y, Di Girolamo R, Vitturi G, Marfia GA, Alviggi C, Bonavita S. Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis. CNS Drugs. 2023 Oct;37(10):849-866. https://doi.org/10.1007/s40263-023-01036-1 PMid:37679579 PMCid:PMC10570169

92. Stern JE, Liu CL, Cui X, Cabral HJ, Farland LV, Coddington C, Diop H. Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis. Fertil Steril. 2022 Jun;117(6):1223-1234. https://doi.org/10.1016/j.fertnstert.2022.02.009 PMid:35397876 PMCid:PMC9149058

93. Akbaribazm M, Goodarzi N, Rahimi M. Female infertility and herbal medicine: An overview of the new findings. Food Sci Nutr. 2021 Aug 15;9(10):5869-5882. https://doi.org/10.1002/fsn3.2523 PMid:34646552 PMCid:PMC8498057

94. Chorosho SH, Malik N, Panesar G, Kumari P, Jangra S, Kaur R, Al-Ghamdi MS, Albishi TS, Chopra H, Singh R, Murthy HCA. Phytochemicals: Alternative for Infertility Treatment and Associated Conditions. Oxid Med Cell Longev. 2023 May 11;2023:1327562. https://doi.org/10.1155/2023/1327562 PMid:37215366 PMCid:PMC10195183

95. Kim E, Lee HW, Kim N, Park YH, Choi TY, Lee MS. Characteristics and Outcomes of Herbal Medicine for Female Infertility: A Retrospective Analysis of Data from a Korean Medicine Clinic During 2010-2020. Int J Womens Health. 2022 Apr 21;14:575-582. https://doi.org/10.2147/IJWH.S361365 PMid:35479292 PMCid:PMC9037743

96. Nasimi Doost Azgomi R, Zomorrodi A, Nazemyieh H, Fazljou SMB, Sadeghi Bazargani H, Nejatbakhsh F, Moini Jazani A, Ahmadi AsrBadr Y. Effects of Withania somnifera on Reproductive System: A Systematic Review of the Available Evidence. Biomed Res Int. 2018 Jan 24;2018:4076430. https://doi.org/10.1155/2018/4076430 PMid:29670898 PMCid:PMC5833251

97. Zhang J, Arshad K, Siddique R, Xu H, Alshammari A, Albekairi NA, Bazmi RR, Hussain L, Lv G. Phytochemicals-based investigation of Rubia cordifolia pharmacological potential against letrozole-induced polycystic ovarian syndrome in female adult rats: In vitro, in vivo and mechanistic approach. Heliyon. 2024 Jul 9;10(14):e34298. https://doi.org/10.1016/j.heliyon.2024.e34298 PMid:39108850 PMCid:PMC11301150

98. Mahmoudian A, Ashouri A, Bilandi RR, Mohammadzadeh F, Dashti S, Bahri N. The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial. J Ovarian Res. 2024 Jul 12;17(1):144. https://doi.org/10.1186/s13048-024-01460-x PMid:38997723 PMCid:PMC11242022

99. Gudise VS, Dasari MP, Kuricheti SSK. Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial. Cureus. 2024 Apr 8;16(4):e57879. https://doi.org/10.7759/cureus.57879 PMid:38725785 PMCid:PMC11079574

100. Moini Jazani A, Hamdi K, Tansaz M, Nazemiyeh H, Sadeghi Bazargani H, Fazljou SMB, Nasimi Doost Azgomi R. Herbal Medicine for Oligomenorrhea and Amenorrhea: A Systematic Review of Ancient and Conventional Medicine. Biomed Res Int. 2018 Mar 18;2018:3052768. https://doi.org/10.1155/2018/3052768 PMid:29744355 PMCid:PMC5878906

101. Bu N, Jamil A, Hussain L, Alshammari A, Albekairi TH, Alharbi M, Jamshed A, Bazmi RR, Younas A. Phytochemical-Based Study of Ethanolic Extract of Saraca asoca in Letrozole-Induced Polycystic Ovarian Syndrome in Female Adult Rats. ACS Omega. 2023 Nov 1;8(45):42586-42597. https://doi.org/10.1021/acsomega.3c05274 PMid:38024692 PMCid:PMC10652831